DNA Script, a Paris, France-based maker of de novo synthetic nucleic acids using an enzymatic technology, raised $38.5M in Series B funding.
TreeFrog Therapeutics, a Bordeaux, France-based stem cell company, raised €7.1M ($7.8M) in Series A funding round.
Provepharm Life Solutions, a Marseille, France-based independent pharmaceutical and life sciences group which revitalizes known molecules, received a €42.5M ($47.6M) syndicated loan.
Pitchboy, a New York and Paris, France-based virtual reality training company, closed a $675K seed funding round.
Fretlink, a Paris, France-based trucking marketplace, raised €25m in Series B funding.
Getaround, a San Francisco, CA-based carsharing company, acquired Drivy, a Paris, France-based carsharing platform, for $300M.
Bankin’, a Paris, France-based app that connects with banks manage money, raised €20m in Series B funding.
360Learning, a Paris, France-based learning engagement platform where leaders and learners connect and collaborate to create a continuous work and learning environment, secured a $41m Series B funding.
Alsid, a Paris, France-based Active Directory protection solution provider, raised €13m in Series A funding.
LumApps, a French provider of a social intranet for the enterprise, closed a $24M Series B funding round.
NH TherAguix, a French startup specializing in nanomedicine for cancer radiotherapy, raised €13m in funding.
BEX Capital, a Nice, France – based investment firm focused exclusively on fund-of-funds (FoF) secondaries, closed BEX Fund III, with total commitments of $365m.
Rivalis, a Colmar, France-based network for SME executive support, received a minority investment from Ardian.
Nestwave, a Paris, France-based provider of advanced geolocation solutions for the IoT market, closed a €2.0m financing round.
Vivet Therapeutics, a Paris, France-based gene therapy biotech company dedicated to developing treatments for inherited liver disorders with high unmet medical need, received a 15% equity investment from Pfizer Inc. (NYSE: PFE).